Omnicell Gross Profit 2011-2025 | OMCL
Omnicell gross profit from 2011 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
|
Omnicell Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2024 | $471 |
| 2023 | $497 |
| 2022 | $589 |
| 2021 | $555 |
| 2020 | $413 |
| 2019 | $437 |
| 2018 | $372 |
| 2017 | $319 |
| 2016 | $317 |
| 2015 | $248 |
| 2014 | $234 |
| 2013 | $203 |
| 2012 | $171 |
| 2011 | $136 |
| 2010 | $118 |
|
Omnicell Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2025-09-30 | $135 |
| 2025-06-30 | $128 |
| 2025-03-31 | $111 |
| 2024-12-31 | $142 |
| 2024-09-30 | $122 |
| 2024-06-30 | $114 |
| 2024-03-31 | $93 |
| 2023-12-31 | $105 |
| 2023-09-30 | $132 |
| 2023-06-30 | $134 |
| 2023-03-31 | $125 |
| 2022-12-31 | $122 |
| 2022-09-30 | $159 |
| 2022-06-30 | $158 |
| 2022-03-31 | $150 |
| 2021-12-31 | $149 |
| 2021-09-30 | $147 |
| 2021-06-30 | $136 |
| 2021-03-31 | $122 |
| 2020-12-31 | $124 |
| 2020-09-30 | $97 |
| 2020-06-30 | $83 |
| 2020-03-31 | $110 |
| 2019-12-31 | $124 |
| 2019-09-30 | $112 |
| 2019-06-30 | $104 |
| 2019-03-31 | $97 |
| 2018-12-31 | $102 |
| 2018-09-30 | $99 |
| 2018-06-30 | $89 |
| 2018-03-31 | $82 |
| 2017-12-31 | $93 |
| 2017-09-30 | $85 |
| 2017-06-30 | $78 |
| 2017-03-31 | $62 |
| 2016-12-31 | $78 |
| 2016-09-30 | $82 |
| 2016-06-30 | $78 |
| 2016-03-31 | $80 |
| 2015-12-31 | $65 |
| 2015-09-30 | $64 |
| 2015-06-30 | $57 |
| 2015-03-31 | $62 |
| 2014-12-31 | $64 |
| 2014-09-30 | $60 |
| 2014-06-30 | $56 |
| 2014-03-31 | $54 |
| 2013-12-31 | $57 |
| 2013-09-30 | $52 |
| 2013-06-30 | $49 |
| 2013-03-31 | $45 |
| 2012-12-31 | $49 |
| 2012-09-30 | $46 |
| 2012-06-30 | $39 |
| 2012-03-31 | $36 |
| 2011-12-31 | $36 |
| 2011-09-30 | $34 |
| 2011-06-30 | $34 |
| 2011-03-31 | $32 |
| 2010-12-31 | $31 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.601B | $1.112B |
| Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.330B | 58.97 |
| Tempus AI (TEM) | United States | $12.432B | 0.00 |
| Doximity (DOCS) | United States | $10.168B | 42.09 |
| Hims & Hers Health (HIMS) | United States | $9.274B | 75.98 |
| IRhythm Technologies (IRTC) | United States | $5.625B | 0.00 |
| Hinge Health (HNGE) | United States | $3.490B | 0.00 |
| Privia Health (PRVA) | United States | $2.876B | 180.23 |
| Heartflow (HTFL) | United States | $2.715B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.376B | 39.32 |
| 10x Genomics (TXG) | United States | $1.898B | 0.00 |
| Enovis (ENOV) | United States | $1.604B | 8.43 |
| Clover Health Investments (CLOV) | United States | $1.368B | 0.00 |
| Azenta (AZTA) | United States | $1.346B | 58.74 |
| Phreesia (PHR) | United States | $1.319B | 0.00 |
| Schrodinger (SDGR) | United States | $1.309B | 0.00 |
| Claritev (CTEV) | United States | $1.141B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.807B | 0.00 |
| Evolent Health (EVH) | United States | $0.583B | 0.00 |
| Talkspace (TALK) | United States | $0.571B | 113.67 |
| Butterfly Network (BFLY) | United States | $0.561B | 0.00 |
| Veradigm (MDRX) | United States | $0.523B | 0.00 |
| Standard BioTools (LAB) | United States | $0.435B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.396B | 0.00 |
| Carlsmed (CARL) | United States | $0.363B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.295B | 0.00 |
| TruBridge (TBRG) | United States | $0.292B | 13.39 |
| CapsoVision (CV) | United States | $0.221B | 0.00 |
| Outset Medical (OM) | United States | $0.214B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.212B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.199B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.180B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.179B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.167B | 0.00 |
| CareCloud (CCLD) | United States | $0.147B | 8.06 |
| EUDA Health Holdings (EUDA) | Singapore | $0.127B | 0.00 |
| Pulmonx (LUNG) | United States | $0.078B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.075B | 0.00 |
| American Well (AMWL) | United States | $0.068B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.057B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.040B | 0.00 |
| 111 (YI) | China | $0.036B | 0.00 |
| Precipio (PRPO) | United States | $0.032B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.026B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.022B | 0.00 |
| Zhongchao (ZCMD) | China | $0.018B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |